Global Hereditary Angioedema Treatment Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Hereditary Angioedema Treatment market covering all its essential aspects.For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.Key players in the global Hereditary Angioedema Treatment market are covered in Chapter 9:CSL Behring
Shire plc.
BIOCRYST PHARMACEUTICALS,INC
Attune Pharmaceuticals
lonis Pharmaceuticals,Inc
Arrowhead Pharmaceuticals,Inc.
Adverum
Pharming Group NV
In Chapter 5 and Chapter 7.3, based on types, the Hereditary Angioedema Treatment market from 2017 to 2027 is primarily split into:C-1 Esterase Inhibitors
Bradykynin Receptor Antagonist
Kallikrein Inhibitors
In Chapter 6 and Chapter 7.4, based on applications, the Hereditary Angioedema Treatment market from 2017 to 2027 covers:Prophylaxis
Treatment
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:United StatesEuropeChinaJapanIndiaSoutheast AsiaLatin AmericaMiddle East and AfricaClient Focus1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Hereditary Angioedema Treatment market? Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Hereditary Angioedema Treatment Industry. 2. How do you determine the list of the key players included in the report? With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth. Please find the key player list in Summary.3. What are your main data sources?Both Primary and Secondary data sources are being used while compiling the report.Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.4. Can I modify the scope of the report and customize it to suit my requirements? Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.OutlineChapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained. Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points. Chapter 11 introduces the market research methods and data sources.Years considered for this report:Historical Years: 2017-2021Base Year: 2021Estimated Year: 2022Forecast Period: 2022-2027
Shire plc.
BIOCRYST PHARMACEUTICALS,INC
Attune Pharmaceuticals
lonis Pharmaceuticals,Inc
Arrowhead Pharmaceuticals,Inc.
Adverum
Pharming Group NV
In Chapter 5 and Chapter 7.3, based on types, the Hereditary Angioedema Treatment market from 2017 to 2027 is primarily split into:C-1 Esterase Inhibitors
Bradykynin Receptor Antagonist
Kallikrein Inhibitors
In Chapter 6 and Chapter 7.4, based on applications, the Hereditary Angioedema Treatment market from 2017 to 2027 covers:Prophylaxis
Treatment
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:United StatesEuropeChinaJapanIndiaSoutheast AsiaLatin AmericaMiddle East and AfricaClient Focus1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Hereditary Angioedema Treatment market? Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Hereditary Angioedema Treatment Industry. 2. How do you determine the list of the key players included in the report? With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth. Please find the key player list in Summary.3. What are your main data sources?Both Primary and Secondary data sources are being used while compiling the report.Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.4. Can I modify the scope of the report and customize it to suit my requirements? Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.OutlineChapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained. Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points. Chapter 11 introduces the market research methods and data sources.Years considered for this report:Historical Years: 2017-2021Base Year: 2021Estimated Year: 2022Forecast Period: 2022-2027
1 HEREDITARY ANGIOEDEMA TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Hereditary Angioedema Treatment Market
1.2 Hereditary Angioedema Treatment Market Segment by Type
1.2.1 Global Hereditary Angioedema Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Hereditary Angioedema Treatment Market Segment by Application
1.3.1 Hereditary Angioedema Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Hereditary Angioedema Treatment Market, Region Wise (2017-2027)
1.4.1 Global Hereditary Angioedema Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.4 China Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.6 India Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Hereditary Angioedema Treatment (2017-2027)
1.5.1 Global Hereditary Angioedema Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Hereditary Angioedema Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Hereditary Angioedema Treatment Market
2 INDUSTRY OUTLOOK
2.1 Hereditary Angioedema Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Hereditary Angioedema Treatment Market Drivers Analysis
2.4 Hereditary Angioedema Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Hereditary Angioedema Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Hereditary Angioedema Treatment Industry Development
3 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Hereditary Angioedema Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Hereditary Angioedema Treatment Average Price by Player (2017-2022)
3.4 Global Hereditary Angioedema Treatment Gross Margin by Player (2017-2022)
3.5 Hereditary Angioedema Treatment Market Competitive Situation and Trends
3.5.1 Hereditary Angioedema Treatment Market Concentration Rate
3.5.2 Hereditary Angioedema Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Hereditary Angioedema Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Hereditary Angioedema Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Hereditary Angioedema Treatment Market Under COVID-19
4.5 Europe Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Hereditary Angioedema Treatment Market Under COVID-19
4.6 China Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Hereditary Angioedema Treatment Market Under COVID-19
4.7 Japan Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Hereditary Angioedema Treatment Market Under COVID-19
4.8 India Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Hereditary Angioedema Treatment Market Under COVID-19
4.9 Southeast Asia Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Hereditary Angioedema Treatment Market Under COVID-19
4.10 Latin America Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Hereditary Angioedema Treatment Market Under COVID-19
4.11 Middle East and Africa Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Hereditary Angioedema Treatment Market Under COVID-19
5 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Hereditary Angioedema Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Hereditary Angioedema Treatment Price by Type (2017-2022)
5.4 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate of C-1 Esterase Inhibitors (2017-2022)
5.4.2 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate of Bradykynin Receptor Antagonist (2017-2022)
5.4.3 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate of Kallikrein Inhibitors (2017-2022)
6 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Hereditary Angioedema Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Hereditary Angioedema Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Hereditary Angioedema Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Hereditary Angioedema Treatment Consumption and Growth Rate of Prophylaxis (2017-2022)
6.3.2 Global Hereditary Angioedema Treatment Consumption and Growth Rate of Treatment (2017-2022)
7 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Hereditary Angioedema Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Hereditary Angioedema Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Hereditary Angioedema Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Hereditary Angioedema Treatment Price and Trend Forecast (2022-2027)
7.2 Global Hereditary Angioedema Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Hereditary Angioedema Treatment Revenue and Growth Rate of C-1 Esterase Inhibitors (2022-2027)
7.3.2 Global Hereditary Angioedema Treatment Revenue and Growth Rate of Bradykynin Receptor Antagonist (2022-2027)
7.3.3 Global Hereditary Angioedema Treatment Revenue and Growth Rate of Kallikrein Inhibitors (2022-2027)
7.4 Global Hereditary Angioedema Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Hereditary Angioedema Treatment Consumption Value and Growth Rate of Prophylaxis(2022-2027)
7.4.2 Global Hereditary Angioedema Treatment Consumption Value and Growth Rate of Treatment(2022-2027)
7.5 Hereditary Angioedema Treatment Market Forecast Under COVID-19
8 HEREDITARY ANGIOEDEMA TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Hereditary Angioedema Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Hereditary Angioedema Treatment Analysis
8.6 Major Downstream Buyers of Hereditary Angioedema Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Hereditary Angioedema Treatment Industry
9 PLAYERS PROFILES
9.1 CSL Behring
9.1.1 CSL Behring Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.1.3 CSL Behring Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Shire plc.
9.2.1 Shire plc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.2.3 Shire plc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 BIOCRYST PHARMACEUTICALS,INC
9.3.1 BIOCRYST PHARMACEUTICALS,INC Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.3.3 BIOCRYST PHARMACEUTICALS,INC Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Attune Pharmaceuticals
9.4.1 Attune Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.4.3 Attune Pharmaceuticals Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 lonis Pharmaceuticals,Inc
9.5.1 lonis Pharmaceuticals,Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.5.3 lonis Pharmaceuticals,Inc Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Arrowhead Pharmaceuticals,Inc.
9.6.1 Arrowhead Pharmaceuticals,Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.6.3 Arrowhead Pharmaceuticals,Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Adverum
9.7.1 Adverum Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.7.3 Adverum Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pharming Group NV
9.8.1 Pharming Group NV Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.8.3 Pharming Group NV Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Hereditary Angioedema Treatment Market
1.2 Hereditary Angioedema Treatment Market Segment by Type
1.2.1 Global Hereditary Angioedema Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Hereditary Angioedema Treatment Market Segment by Application
1.3.1 Hereditary Angioedema Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Hereditary Angioedema Treatment Market, Region Wise (2017-2027)
1.4.1 Global Hereditary Angioedema Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.4 China Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.6 India Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Hereditary Angioedema Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Hereditary Angioedema Treatment (2017-2027)
1.5.1 Global Hereditary Angioedema Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Hereditary Angioedema Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Hereditary Angioedema Treatment Market
2 INDUSTRY OUTLOOK
2.1 Hereditary Angioedema Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Hereditary Angioedema Treatment Market Drivers Analysis
2.4 Hereditary Angioedema Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Hereditary Angioedema Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Hereditary Angioedema Treatment Industry Development
3 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Hereditary Angioedema Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Hereditary Angioedema Treatment Average Price by Player (2017-2022)
3.4 Global Hereditary Angioedema Treatment Gross Margin by Player (2017-2022)
3.5 Hereditary Angioedema Treatment Market Competitive Situation and Trends
3.5.1 Hereditary Angioedema Treatment Market Concentration Rate
3.5.2 Hereditary Angioedema Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Hereditary Angioedema Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Hereditary Angioedema Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Hereditary Angioedema Treatment Market Under COVID-19
4.5 Europe Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Hereditary Angioedema Treatment Market Under COVID-19
4.6 China Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Hereditary Angioedema Treatment Market Under COVID-19
4.7 Japan Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Hereditary Angioedema Treatment Market Under COVID-19
4.8 India Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Hereditary Angioedema Treatment Market Under COVID-19
4.9 Southeast Asia Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Hereditary Angioedema Treatment Market Under COVID-19
4.10 Latin America Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Hereditary Angioedema Treatment Market Under COVID-19
4.11 Middle East and Africa Hereditary Angioedema Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Hereditary Angioedema Treatment Market Under COVID-19
5 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Hereditary Angioedema Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Hereditary Angioedema Treatment Price by Type (2017-2022)
5.4 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate of C-1 Esterase Inhibitors (2017-2022)
5.4.2 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate of Bradykynin Receptor Antagonist (2017-2022)
5.4.3 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Growth Rate of Kallikrein Inhibitors (2017-2022)
6 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Hereditary Angioedema Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Hereditary Angioedema Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Hereditary Angioedema Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Hereditary Angioedema Treatment Consumption and Growth Rate of Prophylaxis (2017-2022)
6.3.2 Global Hereditary Angioedema Treatment Consumption and Growth Rate of Treatment (2017-2022)
7 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Hereditary Angioedema Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Hereditary Angioedema Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Hereditary Angioedema Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Hereditary Angioedema Treatment Price and Trend Forecast (2022-2027)
7.2 Global Hereditary Angioedema Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Hereditary Angioedema Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Hereditary Angioedema Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Hereditary Angioedema Treatment Revenue and Growth Rate of C-1 Esterase Inhibitors (2022-2027)
7.3.2 Global Hereditary Angioedema Treatment Revenue and Growth Rate of Bradykynin Receptor Antagonist (2022-2027)
7.3.3 Global Hereditary Angioedema Treatment Revenue and Growth Rate of Kallikrein Inhibitors (2022-2027)
7.4 Global Hereditary Angioedema Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Hereditary Angioedema Treatment Consumption Value and Growth Rate of Prophylaxis(2022-2027)
7.4.2 Global Hereditary Angioedema Treatment Consumption Value and Growth Rate of Treatment(2022-2027)
7.5 Hereditary Angioedema Treatment Market Forecast Under COVID-19
8 HEREDITARY ANGIOEDEMA TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Hereditary Angioedema Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Hereditary Angioedema Treatment Analysis
8.6 Major Downstream Buyers of Hereditary Angioedema Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Hereditary Angioedema Treatment Industry
9 PLAYERS PROFILES
9.1 CSL Behring
9.1.1 CSL Behring Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.1.3 CSL Behring Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Shire plc.
9.2.1 Shire plc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.2.3 Shire plc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 BIOCRYST PHARMACEUTICALS,INC
9.3.1 BIOCRYST PHARMACEUTICALS,INC Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.3.3 BIOCRYST PHARMACEUTICALS,INC Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Attune Pharmaceuticals
9.4.1 Attune Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.4.3 Attune Pharmaceuticals Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 lonis Pharmaceuticals,Inc
9.5.1 lonis Pharmaceuticals,Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.5.3 lonis Pharmaceuticals,Inc Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Arrowhead Pharmaceuticals,Inc.
9.6.1 Arrowhead Pharmaceuticals,Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.6.3 Arrowhead Pharmaceuticals,Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Adverum
9.7.1 Adverum Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.7.3 Adverum Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pharming Group NV
9.8.1 Pharming Group NV Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Hereditary Angioedema Treatment Product Profiles, Application and Specification
9.8.3 Pharming Group NV Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Hereditary Angioedema Treatment Product Picture
Table Global Hereditary Angioedema Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Hereditary Angioedema Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Hereditary Angioedema Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Hereditary Angioedema Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Hereditary Angioedema Treatment Industry Development
Table Global Hereditary Angioedema Treatment Sales Volume by Player (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume Share by Player (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Share by Player in 2021
Table Hereditary Angioedema Treatment Revenue (Million USD) by Player (2017-2022)
Table Hereditary Angioedema Treatment Revenue Market Share by Player (2017-2022)
Table Hereditary Angioedema Treatment Price by Player (2017-2022)
Table Hereditary Angioedema Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Hereditary Angioedema Treatment Sales Volume, Region Wise (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Hereditary Angioedema Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Hereditary Angioedema Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share, Region Wise in 2021
Table Global Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume by Type (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Market Share by Type in 2021
Table Global Hereditary Angioedema Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Type in 2021
Table Hereditary Angioedema Treatment Price by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate of C-1 Esterase Inhibitors (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of C-1 Esterase Inhibitors (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate of Bradykynin Receptor Antagonist (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Bradykynin Receptor Antagonist (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate of Kallikrein Inhibitors (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Kallikrein Inhibitors (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption Market Share by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption and Growth Rate of Prophylaxis (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption and Growth Rate of Treatment (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Hereditary Angioedema Treatment Price and Trend Forecast (2022-2027)
Figure USA Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Hereditary Angioedema Treatment Market Sales Volume Forecast, by Type
Table Global Hereditary Angioedema Treatment Sales Volume Market Share Forecast, by Type
Table Global Hereditary Angioedema Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Hereditary Angioedema Treatment Revenue Market Share Forecast, by Type
Table Global Hereditary Angioedema Treatment Price Forecast, by Type
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of C-1 Esterase Inhibitors (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of C-1 Esterase Inhibitors (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Bradykynin Receptor Antagonist (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Bradykynin Receptor Antagonist (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Kallikrein Inhibitors (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Kallikrein Inhibitors (2022-2027)
Table Global Hereditary Angioedema Treatment Market Consumption Forecast, by Application
Table Global Hereditary Angioedema Treatment Consumption Market Share Forecast, by Application
Table Global Hereditary Angioedema Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Hereditary Angioedema Treatment Revenue Market Share Forecast, by Application
Figure Global Hereditary Angioedema Treatment Consumption Value (Million USD) and Growth Rate of Prophylaxis (2022-2027)
Figure Global Hereditary Angioedema Treatment Consumption Value (Million USD) and Growth Rate of Treatment (2022-2027)
Figure Hereditary Angioedema Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table CSL Behring Profile
Table CSL Behring Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CSL Behring Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure CSL Behring Revenue (Million USD) Market Share 2017-2022
Table Shire plc. Profile
Table Shire plc. Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shire plc. Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Shire plc. Revenue (Million USD) Market Share 2017-2022
Table BIOCRYST PHARMACEUTICALS,INC Profile
Table BIOCRYST PHARMACEUTICALS,INC Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BIOCRYST PHARMACEUTICALS,INC Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure BIOCRYST PHARMACEUTICALS,INC Revenue (Million USD) Market Share 2017-2022
Table Attune Pharmaceuticals Profile
Table Attune Pharmaceuticals Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Attune Pharmaceuticals Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Attune Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table lonis Pharmaceuticals,Inc Profile
Table lonis Pharmaceuticals,Inc Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure lonis Pharmaceuticals,Inc Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure lonis Pharmaceuticals,Inc Revenue (Million USD) Market Share 2017-2022
Table Arrowhead Pharmaceuticals,Inc. Profile
Table Arrowhead Pharmaceuticals,Inc. Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arrowhead Pharmaceuticals,Inc. Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Arrowhead Pharmaceuticals,Inc. Revenue (Million USD) Market Share 2017-2022
Table Adverum Profile
Table Adverum Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Adverum Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Adverum Revenue (Million USD) Market Share 2017-2022
Table Pharming Group NV Profile
Table Pharming Group NV Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharming Group NV Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Pharming Group NV Revenue (Million USD) Market Share 2017-2022
Figure Hereditary Angioedema Treatment Product Picture
Table Global Hereditary Angioedema Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Hereditary Angioedema Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Hereditary Angioedema Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Hereditary Angioedema Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Hereditary Angioedema Treatment Industry Development
Table Global Hereditary Angioedema Treatment Sales Volume by Player (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume Share by Player (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Share by Player in 2021
Table Hereditary Angioedema Treatment Revenue (Million USD) by Player (2017-2022)
Table Hereditary Angioedema Treatment Revenue Market Share by Player (2017-2022)
Table Hereditary Angioedema Treatment Price by Player (2017-2022)
Table Hereditary Angioedema Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Hereditary Angioedema Treatment Sales Volume, Region Wise (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Hereditary Angioedema Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Hereditary Angioedema Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share, Region Wise in 2021
Table Global Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume by Type (2017-2022)
Table Global Hereditary Angioedema Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume Market Share by Type in 2021
Table Global Hereditary Angioedema Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Hereditary Angioedema Treatment Revenue Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Type in 2021
Table Hereditary Angioedema Treatment Price by Type (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate of C-1 Esterase Inhibitors (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of C-1 Esterase Inhibitors (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate of Bradykynin Receptor Antagonist (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Bradykynin Receptor Antagonist (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate of Kallikrein Inhibitors (2017-2022)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Kallikrein Inhibitors (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption Market Share by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption and Growth Rate of Prophylaxis (2017-2022)
Table Global Hereditary Angioedema Treatment Consumption and Growth Rate of Treatment (2017-2022)
Figure Global Hereditary Angioedema Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Hereditary Angioedema Treatment Price and Trend Forecast (2022-2027)
Figure USA Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Hereditary Angioedema Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Hereditary Angioedema Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Hereditary Angioedema Treatment Market Sales Volume Forecast, by Type
Table Global Hereditary Angioedema Treatment Sales Volume Market Share Forecast, by Type
Table Global Hereditary Angioedema Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Hereditary Angioedema Treatment Revenue Market Share Forecast, by Type
Table Global Hereditary Angioedema Treatment Price Forecast, by Type
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of C-1 Esterase Inhibitors (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of C-1 Esterase Inhibitors (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Bradykynin Receptor Antagonist (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Bradykynin Receptor Antagonist (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Kallikrein Inhibitors (2022-2027)
Figure Global Hereditary Angioedema Treatment Revenue (Million USD) and Growth Rate of Kallikrein Inhibitors (2022-2027)
Table Global Hereditary Angioedema Treatment Market Consumption Forecast, by Application
Table Global Hereditary Angioedema Treatment Consumption Market Share Forecast, by Application
Table Global Hereditary Angioedema Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Hereditary Angioedema Treatment Revenue Market Share Forecast, by Application
Figure Global Hereditary Angioedema Treatment Consumption Value (Million USD) and Growth Rate of Prophylaxis (2022-2027)
Figure Global Hereditary Angioedema Treatment Consumption Value (Million USD) and Growth Rate of Treatment (2022-2027)
Figure Hereditary Angioedema Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table CSL Behring Profile
Table CSL Behring Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CSL Behring Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure CSL Behring Revenue (Million USD) Market Share 2017-2022
Table Shire plc. Profile
Table Shire plc. Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shire plc. Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Shire plc. Revenue (Million USD) Market Share 2017-2022
Table BIOCRYST PHARMACEUTICALS,INC Profile
Table BIOCRYST PHARMACEUTICALS,INC Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BIOCRYST PHARMACEUTICALS,INC Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure BIOCRYST PHARMACEUTICALS,INC Revenue (Million USD) Market Share 2017-2022
Table Attune Pharmaceuticals Profile
Table Attune Pharmaceuticals Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Attune Pharmaceuticals Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Attune Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table lonis Pharmaceuticals,Inc Profile
Table lonis Pharmaceuticals,Inc Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure lonis Pharmaceuticals,Inc Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure lonis Pharmaceuticals,Inc Revenue (Million USD) Market Share 2017-2022
Table Arrowhead Pharmaceuticals,Inc. Profile
Table Arrowhead Pharmaceuticals,Inc. Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Arrowhead Pharmaceuticals,Inc. Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Arrowhead Pharmaceuticals,Inc. Revenue (Million USD) Market Share 2017-2022
Table Adverum Profile
Table Adverum Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Adverum Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Adverum Revenue (Million USD) Market Share 2017-2022
Table Pharming Group NV Profile
Table Pharming Group NV Hereditary Angioedema Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharming Group NV Hereditary Angioedema Treatment Sales Volume and Growth Rate
Figure Pharming Group NV Revenue (Million USD) Market Share 2017-2022
